Venture capital.
Capital, you know, that's always good in a capitalist country. It means money to begin a venture, or adventure as the case may be. Who could be against raising money for an adventure?
"Venture funding inches up; New England investment rises for second quarter in a row" by Robert Weisman, Globe Staff | October 20, 2009
Venture capital investing edged up nationally last quarter for the first time in 18 months, suggesting the funding decline for technology and life sciences start-ups may have bottomed out, according to the quarterly MoneyTree venture report released yesterday....
What is venture capital? Where does it come from?
Related: Who Stole Your Pension, America?
Answer: The Vampires of Biotech
Also see: Taxpayers Drop Biotech Baton
Slow Saturday Special: VenCap Cash Out
VenCap Vroom-Vroom
So are we clear on that, readers.
What sounds so benign and harmless -- venture capital -- is a RIP-OFF SCHEME!!!
Now you know WHY your PENSIONS -- "tattered investment holdings"
" -- have tanked and NOT COME BACK (market rose, wtf?) and why COLLEGE TUITIONS are RISING through the ROOF!
YOU WAZ ROBBED, 'murka!!!
Among sectors nationwide, biotechnology companies drew the most money last quarter - $905 million. Energy and industrial start-ups came in second with $864 million, surpassing computer software companies - traditionally the first- or second-largest funding recipients - which attracted $622 million.
See: EMC Moving Out of Massachusetts
Rounding out the sectors were medical-device companies, which drew $617 million, and media and entertainment businesses, which attracted $446 million on the strength of a $100 million financing round for San Francisco blog services provider Twitter Inc.
So you have TAXPAYER, SCHOOL ENDOWMENTS, and PENSION being directed to all these AGENDA-PUSHING and SELF-SERVING INTERESTS who BURN THROUGH the $$$ and RARELY PRODUCE a PROFIT or a PRODUCT!
Also see: Slow Saturday Special: Waiting For the Bell to Ring
Can't you FIND SOMETHING BETTER to do with YOUR MONEY, America?
The largest deal last quarter was a $286 million funding round for Solyndra Inc., a Fremont, Calif., company that designs and makes solar energy technology, helping to propel the energy and industrial sector. Four of the top 10 national deals in the quarter went to energy and industrial firms.
Related: Slow Saturday Special: Evergreen Turns Brown
But in New England, biotechnology dominated, with the top four funding deals - and seven of the 10 biggest - going to biotech start-ups. The region’s largest deal during the quarter was the $32 million raised by Epizyme Inc., a Cambridge company using gene regulation to develop drugs to treat cancer and other diseases.
“Biotech is taking the lead here,’’ said PricewaterhouseCoopers’s Shaw. “It’s not surprising, given the kind of companies we have here, the universities, and the hospitals.’’
Venture capitalists yesterday said they expect investing will continue to rise in the fourth quarter and next year, largely because of the improving financial markets....
Then HOW COME the PENSION STATEMENT still looks like dogs***?
Also see: The Boston Globe's Invisible Ink: Jobs Gone Forever
